MSH|^~\&|LAB|SMH|||202001031501||ORU^R01|4138823|D|2.3|||AL|NE
PID|1||SM00044281|RC6243|LABTEST^ACADEMIC^||20180321|M||||||||||SM005226/18|9876209312
OBR|1|37415^LAB|00028128^0301:C00003R^LAB^030120:C3^37415|520.4200^IRON^Iron Studies Profile^^^50190-8||202001031328|202001031030|||||||202001031327||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|25^^Y|umol/L|9-30|N||A^S|F|||202001031501
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|35^^Y|umol/L|45-70|L||A^S|F|||202001031501
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.71^^Y||0.15-0.55|H||A^S|F|||202001031501
NTE|1||Markedly elevated transferrin saturation.  Follow up and
NTE|2||management as per BCMA/MSP Iron Overload protocol.